New VitA-Pos Eye Ointment Introduced for night time use

AFT Pharmaceuticals is pleased to announce the launch of the new VitA-POS® eye ointment to the Australian market.

VitA-POS® is a smooth, preservative-free eye ointment containing Vitamin A that prevents evaporation from the ocular surface during the night.

It improves the tear film and provides valuable protection of the ocular surface during sleep for all forms and severity of dry eye. VitA-POS® is both preservative-free and phosphate-free, and contains the equivalent of 250 IU of Vitamin A per gram.

VitA-POS® eye ointment also has a use-up period of six months after opening, and more than 300 applications are possible from a 5g pack.

Find out more about VitA-POS®

May 1, 2024

AFT Licenses Maxigesic® IV in Brazil

We are delighted to announce our partnership with Brazil’s Halex Istar, and to be exclusively responsible for distributing its Maxigesic IV in Brazi…

Read More

April 24, 2024

AFT, Massey Ventures, Gilles McIndoe to develop scar treatment

AFT collaborate with Massey Ventures and Gilles McIndoe to begin the development of a topical treatment for keloid and hypertrophic scarring….

Read More

March 5, 2024

AFT makes further progress in international markets

AFT Pharmaceuticals provides an update on recent progress it has made in international markets….

Read More